Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy and adverse effects of Azacitidine in combination with R-CHOP (ARCHOP) for the treatment of TP53-mutated previously untreated Diffuse large B-cell lymphoma


Clinical Trial Description

This is a Phase 2, open-label clinical trial study that aims to evaluate the efficacy (eg. Complete response, Overall Survival, Progression Free Survival) and adverse effects of Azacitidine in combination with R-CHOP (ARCHOP) for the treatment of TP53-mutated previously untreated Diffuse large B-cell lymphoma ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06158399
Study type Interventional
Source The First Affiliated Hospital of Xiamen University
Contact Bing Xu
Phone +8618750918842
Email xubingzhangjian@126.com
Status Recruiting
Phase Phase 2
Start date November 22, 2023
Completion date May 31, 2025